跳至主要内容
临床试验/NCT02175290
NCT02175290Unknown不适用

Machado-Joseph Disease in Israel: Clinical Phenotype and Genotype of a Jew Yemenite Subpopulation

Meir Medical Center1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
250
试验地点
1
主要终点
clinical phenotype of SCA3 Yemenite Jews patients

研究概览

简要总结

Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA-3) is the most common dominant ataxia. The genetic cause of this late-onset degenerative disorder is the expansion of a (CAG)n tract located in the exonic region of the ATXN3 gene. In 1994 the first case of MJD among the Yemenite Jewish subpopulation living in Israel was published. The puropse of this study is to describe the clinical phenotype and genotype of the Yemenite Jewish subpopulation with MJD living in Israel

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Spinocerebellar Ataxia 3 Yemenite Jews patients

排除标准

  • All others

结局指标

主要结局

clinical phenotype of SCA3 Yemenite Jews patients

时间窗: 3 years

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Machado-Joseph Disease in Israel | 临床试验